Categories of Common Antimicrobial Drug Therapy Problems

with selected examples; not an exhaustive list

Therapeutic duplication or drug may not be necessary

Discontinue an antibiotic that duplicates coverage.
e.g. Received a new prescription for oral vancomycin for Clostridium difficile infection; discontinue current metronidazole treatment, if appropriate.i

 

Discontinue antibiotic if there is no bacterial infection.

e.g. An otherwise healthy adult is prescribed amoxicillin for acute bronchitis, with no evidence of pneumonia. Acute bronchitis is self-limiting and more than 90% viral, hence antibiotics are not recommended. Recommend discontinuing amoxicillin and offer symptom management.ii, iii

Requires drug; patient needs additional drug therapy

Add drug therapy if no drug was prescribed for an indication.

e.g. Request a prescription analgesic if patient presents with pain while being on an antibiotic treatment for wound infection due to sub-optimal response with OTC pain reliever.

 

Sub-optimal response to a drug; drug is not working as well as needed

Change antibiotic if culture and susceptibility report indicates bacterial infection that is not covered by empiric therapy.

e.g. An adult on penicillin for outpatient community-acquired pneumonia (CAP) has not improved in 72 hours, and culture results indicate mycoplasma pneumoniae.iv, v Recommend doxycycline 100mg PO BID, or a macrolide if local resistance patterns.iv, v

Dosage is too low

Increase antibiotic dose if it is incorrect based on patient’s weight.

e.g. A 15 kg child is prescribed amoxicillin 150 mg TID (30mg/kg/day) for acute otitis media. The recommended dose of amoxicillin is 40-50 mg/kg/day divided TID; or 75-90 mg/kg/day divided.vi Recommend 250mg TID (50mg/kg/day).vii

Adverse drug reaction (allergy, interaction, side effect)

Change antibiotic if cross-allergenicity between antibiotics is a concern.

e.g. Discontinue cephalexin and start clindamycin for non-purulent cellulitis if patient presents with severe beta-lactam allergy (history of severe cutaneous reaction).viii

Dangerously high dose or accidental or purposeful overdosing​

Decrease antibiotic dose according to renal function.

e.g. A patient with a creatinine clearance of 20 mL/min is prescribed sulfamethoxazole-trimethoprim at the usual, unadjusted regimen for acute cystitis; recommended dose is half the usual dose.ix

 

Decrease length of treatment if prescribed duration of therapy is longer than the standard dosing regimen for the indication.

e.g. Patient prescribed nitrofurantoin x 7 days for acute cystitis, recommended duration of therapy is 5 days.x

Non-compliance; patient is refusing to take drug or taking it improperly

Consider patient convenience.

e.g. A child is prescribed amoxicillin TID x 10 days for Group A Streptococcal pharyngitis, however parents report difficulty with adherence. Recommend amoxicillin 50mg/kg (maximum 1000mg per day) PO once daily x 10 days.xi,xii Note: switching to azithromycin is not recommended due to resistance to macrolides; reserve for severe allergy to penicillins.xi, xii

Common Myths about Antibiotics that Patients may Believe
Antibiotics can cure my cold or flu.

Antibiotics treat bacterial infections, while antivirals treat viral infections.xiii To effectively treat viral infections, such as the common cold or influenza, keep yourself hydrated and get plenty of rest. Consider getting vaccinated against viral and/or bacterial infections to prevent the overuse and misuse of antibiotics which drive resistance.xiii

Vaccines help prevent infections and reduce antibiotic use, the World Health Organization (WHO) estimates that greater use of existing vaccines and development of new vaccines against 23 pathogens could reduce the antibiotic use by 22%, equivalent to 2.5 billion defined daily doses globally every year.xiv

I cannot take penicillin because I am allergic to it.

Before reporting a penicillin allergy, have you taken an allergy test? Penicillin allergy is often over-reported; about 10% of people carry a penicillin allergy label, however most are not truly allergic when assessed.xv This limits the use of beta lactams and results in sub-optimal therapeutic responses and adverse events.xv Ask your pharmacist to review what happened. Low-risk histories can often be cleared, which opens up safer, narrower antibiotic choices.xvi

A longer course of antibiotics is always better.

For many common infections (such as urinary tract infections, respiratory tract infections, and skin and soft tissue infections) shorter antibiotic courses are as effective as longer courses and reduce unnecessary antibiotic exposure which can lead to an increased risk of side effects, antibiotic resistance and secondary infections.xvii Never save or share leftover antibiotics; bring them back to the pharmacy for safe disposal.xvii

References

i Kao D. Diarrhea. In: Compendium of Pharmaceuticals and Specialties. Canadian Pharmacists Association. Updated December 7, 2023. Accessed October 7, 2026. https://hub.pharmacists.ca/login

 

ii Canadian Pharmacists Association. Common community infections: key clinical pearls. August 2023. Accessed October 7, 2026. https://www.pharmacists.ca/cpha-ca/assets/File/education-practice-resources/Common_Community_Infections_Key_Clinical_Pearls.pdf

 

iii Choosing Wisely Canada. Using Antibiotics Wisely in Primary Care. Accessed October 7, 2026. https://choosingwiselycanada.org/primary-care/antibiotics/

 

iv Loeb M. Community Acquired Pneumonia. In: Compendium of Pharmaceuticals and Specialties. Canadian Pharmacists Association. Updated April 2, 2025. Accessed October 7, 2026. https://hub.pharmacists.ca/login

 

v Nova Scotia Health. Community Acquired Pneumonia in Adults. Nova Scotia Health Antimicrobial Handbook. Updated November 2025. Accessed October 7, 2026. https://library.nshealth.ca/ld.php?content_id=35148941

 

vi Le Saux N, Robinson JL. Position Statement: Management of acute otitis media in children six months of age and older. Canadian Paediatric Society. Updated November 21, 2024. Accessed October 7, 2026. https://cps.ca/en/documents/position/acute-otitis-media

 

vii Vayalumkal JV. Acute Otitis Media in Children. In: Compendium of Pharmaceuticals and Specialties. Canadian Pharmacists Association. Updated January 9, 2025. Accessed October 7, 2026. https://hub.pharmacists.ca/login

 

viii Grant JM, Lao TTM. Bacterial Skin Infections. In: Compendium of Pharmaceuticals and Specialties. Canadian Pharmacists Association. Updated December 17, 2025. Accessed October 7, 2026. https://hub.pharmacists.ca/login

 

ix McCormack J, Carleton B, Calissi P. Dosage Adjustment in Renal Impairment. In: Compendium of Pharmaceuticals and Specialties. Canadian Pharmacists Association. Updated March 13, 2026. Accessed October 7, 2026. https://hub.pharmacists.ca/login

 

x Nicolle L. Urinary Tract Infection. In: Compendium of Therapeutics for Choices. Canadian Pharmacists Association. Updated May 31, 2024. Accessed October 7, 2026. https://hub.pharmacists.ca/login

 

xi Sauve L, Forrester AM, Top KA. Practice Point: Group A streptococcal (GAS) pharyngitis: A practical guide to diagnosis and treatment. Canadian Paediatric Society. Posted July 29, 2021. Accessed October 7, 2026. https://cps.ca/en/documents/position/group-a-streptococcal

 

xii Ciccotelli WC. Group A Streptococcal Pharyngitis. In: Compendium of Therapeutics for Choices. Canadian Pharmacists Association. Updated November 15, 2023. Accessed October 7, 2026. https://hub.pharmacists.ca/login

 

xiii Choosing Wisely Canada. The Cold Standard. The College of Family Physicians of Canada. Updated November 2024. Accessed October 7, 2026. https://choosingwiselycanada.org/wp-content/uploads/dlm_uploads/2024/07/RTI_Toolkit_V5_2024.pdf

 

xiv World Health Organization. News Release: Better use of vaccines could reduce antibiotic use by 2.5 billion doses annually. Geneva: WHO. October 2024. Accessed October 7, 2026. https://www.who.int/news/item/10-10-2024-better-use-of-vaccines-could-reduce-antibiotic-use-by-2.5-billion-doses-annually–says-who

 

xv Jeimy S, Ben-Shoshan M, Abrams EM, Ellis AK, Connors L, Wong T. Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology. Allergy Asthma Clin Immunol. 2020;16:95. doi:10.1186/s13223-020-00494-2.

 

xvi Kamaliddin C, Driver A, Druken R, et al. Feasibility and impact of pharmacist-led penicillin allergy delabelling using the PEN-FAST scoring tool in a Canadian tertiary care hospital. Antimicrob Steward Healthc Epidemiol. 2026; 6(1):e49. doi:10.1017/ash.2026.10297.

 

xvii Canadian Pharmacists Association. Optimizing duration of therapy: is shorter smarter? August 2023. Accessed October 7, 2026. https://www.pharmacists.ca/cpha-ca/assets/File/education-practice-resources/Antimicrobial_Stewardship.pdf

 

 

 

Disclaimer


This resource was developed by the Ontario Pharmacists Association (OPA) in accordance with OPA’s Commitment to Content Quality and Integrity and is provided to pharmacy professionals for informational purposes only. It is intended to assist pharmacy professionals with identifying antimicrobial therapy problems but does not replace professional judgment and responsibilities. Some information may not be up to date but is provided for reference purposes. It is provided without warranty of any kind by OPA and OPA assumes no responsibility for any errors, omissions or inaccuracies therein. The decision for use and application of this information is the responsibility of the user. OPA assumes no liability for such use and application or any resulting outcomes. It is the responsibility of the pharmacy professional to use professional judgment in evaluating this material in light of any relevant clinical or situational data. It is intended to supplement materials provided by regulatory authorities, and should there be any discrepancies, municipal, provincial, and federal laws, policies and guidelines shall prevail. Pharmacy professionals are encouraged to use other resources that are appropriate and available to them. Unauthorized reproduction or use of this tool, in whole or in part, is prohibited without the express written permission of OPA.

Updated: October 16, 2026